V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330007051 | 330010382 | 0 | 59 | Adjuvant (A) | 2015-08-29 | 2015-08-29 | Cisplatin | N | N | 330007528 | CISPLATIN |
| 330007052 | 330010382 | 1.68 | 69 | Adjuvant (A) | 2012-12-04 | 2013-09-30 | EW EuroEwing 2012 Arm B IE | N | N | 330007528 | TRIAL |
| 330007053 | 330010382 | 0 | null | Curative (C) | 2018-04-17 | 2018-04-21 | Cisplatin 7 day | 02 | Y | 330007528 | CISPLATIN |
| 330007054 | 330010382 | 1.65 | 63.3 | Palliative (P) | 2015-08-07 | 2015-10-22 | Cisplatin | N | N | 330007528 | CISPLATIN |
| 330007055 | 330003837 | null | 12 | Adjuvant (A) | 2015-09-22 | 2015-09-22 | DOXORUBICIN | Y | N | 330007540 | DOXORUBICIN |
| 330007056 | 330003839 | 1.67 | 53.4 | Curative (C) | 2014-07-01 | 2014-07-09 | Trial Unspecified | null | null | 330007542 | TRIAL |
| 330007057 | 330003843 | 0 | 91 | Curative (C) | 2015-08-21 | 2015-09-25 | OST Euramos 1 Closed Trial - A | 02 | Y | 330007547 | DOXORUBICIN |
| 330007058 | 330003844 | 1.71 | null | Palliative (P) | 2015-03-26 | 2015-09-13 | EW EuroEwing 2012 Arm B IE | N | N | 330007554 | TRIAL |
| 330007059 | 330008081 | 0 | 0 | Palliative (P) | 2016-10-29 | 2016-10-29 | DOXORUBICIN | 02 | N | 330007556 | DOXORUBICIN |
| 330007060 | 330003845 | 1.62 | 12.8 | Curative (C) | 2015-08-04 | 2015-08-13 | MIFAMURTIDE | 01 | Y | 330007560 | MIFAMURTIDE |
| 330007061 | 330003847 | 1.83 | 43.5 | Palliative (P) | 2013-12-22 | 2015-01-04 | EW EuroEwing 2012 Arm B IE | 02 | N | 330007561 | TRIAL |
| 330007062 | 330003848 | 1.6 | 77.4 | Curative (C) | 2014-05-10 | 2014-06-08 | Methotrexate + Folinic acid | 2 | N | 330007562 | METHOTREXATE |
| 330007063 | 330003849 | 1.82 | 69.3 | Neo-adjuvant (N) | null | 2016-08-20 | Etoposide + Ifosfamide (3 days) | 02 | null | 330007563 | ETOPOSIDE + IFOSFAMIDE |
| 330007064 | 330003850 | 1.71 | null | Palliative (P) | 2013-12-17 | 2014-01-20 | Docetaxel + Gemcitabine (prior RT) | N | Y | 330007570 | DOCETAXEL + GEMCITABINE |
| 330007065 | 330003850 | 1.55 | 68 | Curative (C) | 2018-09-23 | 2018-10-14 | Rituximab | null | null | 330007570 | RITUXIMAB |
| 330007066 | 330012372 | 1.7 | 114 | Palliative (P) | 2018-06-11 | 2018-06-17 | Etoposide + Ifosfamide (5 days) | 02 | N | 330007576 | ETOPOSIDE + IFOSFAMIDE |
| 330007067 | 330003851 | 1.74 | 63.4 | Curative (C) | 2017-02-14 | 2017-04-08 | DOCETAXEL + GEMCITABINE | 02 | N | 330007579 | DOCETAXEL + GEMCITABINE |
| 330007068 | 330003852 | 1.71 | 62 | Palliative (P) | 2018-04-16 | 2018-04-16 | Docetaxel + Gemcitabine (prior RT) | N | N | 330007579 | DOCETAXEL + GEMCITABINE |
| 330007069 | 330003853 | 1.6 | 36.1 | null | 2013-11-25 | 2013-12-02 | Cetuximab 7 day (>Cycle 2) | N | N | 330007583 | CETUXIMAB |
| 330007070 | 330008088 | 1.51 | 58 | Curative (C) | 2013-06-10 | 2013-07-05 | Rituximab (INTRAVENOUS Maintenance) | 02 | N | 330007584 | RITUXIMAB |
| 330007071 | 330003855 | 1.83 | 94 | Neo-adjuvant (N) | 2016-12-05 | 2016-12-09 | Etoposide + Ifosfamide (5 days) | N | N | 330007585 | ETOPOSIDE + IFOSFAMIDE |
| 330007072 | 330003856 | 1.6 | 24.6 | Neo-adjuvant (N) | null | 2012-09-13 | Etoposide + Ifosfamide (3 days) | 02 | N | 330007587 | ETOPOSIDE + IFOSFAMIDE |
| 330007073 | 330003859 | 1.77 | 69 | null | 2014-10-21 | 2014-11-04 | Docetaxel + Gemcitabine (prior RT) | 02 | N | 330007588 | DOCETAXEL + GEMCITABINE |
| 330007074 | 330003861 | 1.74 | 75.9 | Curative (C) | 2014-01-26 | 2014-02-11 | ETOPOSIDE + IFOSFAMIDE | N | N | 330007591 | ETOPOSIDE + IFOSFAMIDE |
| 330007075 | 330003862 | null | null | Curative (C) | 2017-12-13 | 2018-01-21 | Rituximab | 02 | Y | 330007591 | RITUXIMAB |
| 330007076 | 330003863 | null | 77.9 | Neo-adjuvant (N) | 2014-02-25 | 2014-03-12 | Cisplatin +Fluorouracil (3 wk) | N | N | 330007597 | CISPLATIN + FLUOROURACIL |
| 330007077 | 330008092 | 1.73 | null | Disease modification (D) | 2013-08-11 | 2013-08-18 | Rituximab | N | N | 330007601 | RITUXIMAB |
| 330007078 | 330008092 | 1.81 | 71.8 | Curative (C) | 2017-05-04 | 2017-05-11 | Rituximab | N | N | 330007601 | RITUXIMAB |
| 330007079 | 330012771 | 1.68 | 75.8 | Curative (C) | 2013-12-02 | 2014-01-13 | Carboplatin AUC 2 - 5 | 2 | N | 330007603 | CARBOPLATIN |
| 330007083 | 330003870 | 1.78 | 69 | null | 2013-12-23 | 2013-12-23 | CETUXIMAB | 2 | N | 330007616 | CETUXIMAB |
| 330007084 | 330003871 | 1.55 | 42.7 | Curative (C) | 2015-05-16 | 2015-06-06 | PAM x 2 post-surgery (cycles 3&4) | N | N | 330007623 | MAP |
| 330007085 | 330003873 | 1.72 | 62.8 | Palliative (P) | null | 2016-02-22 | Cisplatin +Fluorouracil (3 wk) | 02 | null | 330007628 | CISPLATIN + FLUOROURACIL |
| 330007086 | 330008099 | 1.71 | 37.4 | Neo-adjuvant (N) | 2014-05-03 | 2014-06-01 | OST Euramos 1 Closed Trial - AP | N | N | 330007628 | MAP |
| 330007087 | 330003875 | null | 71.9 | Curative (C) | 2013-08-17 | 2013-11-26 | Carboplatin AUC 6 - 10 | N | N | 330007645 | CARBOPLATIN |
| 330007088 | 330003875 | 1.54 | 42 | Curative (C) | null | 2015-05-11 | CISPLATIN + FLUOROURACIL | null | null | 330007645 | CISPLATIN + FLUOROURACIL |
| 330007089 | 330003875 | 1.79 | null | Palliative (P) | 2013-04-05 | 2013-04-05 | Cetuximab 7 day (>Cycle 2) | 02 | null | 330007645 | CETUXIMAB |
| 330007090 | 330003875 | null | 100 | Palliative (P) | 2015-08-18 | 2015-09-16 | Docetaxel+Gemcitabine (no prior RT) | N | N | 330007645 | DOCETAXEL + GEMCITABINE |
| 330007091 | 330003876 | null | null | Palliative (P) | 2016-12-09 | 2017-01-06 | Rituximab (Maintenance) | N | N | 330007660 | RITUXIMAB |
| 330007093 | 330003880 | 1.72 | 57.9 | Neo-adjuvant (N) | 2014-04-19 | 2014-05-10 | Etoposide + Ifosfamide (3 days) | 2 | N | 330007663 | ETOPOSIDE + IFOSFAMIDE |
| 330007094 | 330003881 | null | null | Disease modification (D) | 2015-06-27 | 2015-07-11 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 330007665 | RITUXIMAB |
| 330007095 | 330003882 | null | 47.2 | Curative (C) | 2017-07-30 | 2017-08-31 | Rituximab | null | null | 330007666 | RITUXIMAB |
| 330007096 | 330010394 | 1.52 | 52 | Adjuvant (A) | 2014-08-10 | 2014-09-05 | Cetuximab 7 day (>Cycle 2) | N | N | 330007672 | CETUXIMAB |
| 330007097 | 330003885 | 1.66 | 60.5 | null | 2015-02-23 | 2015-03-14 | Cetuximab 7 day (>Cycle 2) | N | N | 330007673 | CETUXIMAB |
| 330007098 | 330008106 | 1.79 | 63.7 | Palliative (P) | 2015-06-12 | 2015-06-18 | Etoposide + Ifosfamide (3 days) | 02 | N | 330007676 | ETOPOSIDE + IFOSFAMIDE |
| 330007099 | 330003886 | 1.75 | 99 | Palliative (P) | null | 2018-05-07 | CISPLATIN + FLUOROURACIL | 02 | N | 330007676 | CISPLATIN + FLUOROURACIL |
| 330007100 | 330003886 | null | 90 | Not known (9) | 2016-10-28 | 2016-11-05 | OST Euramos 1 Closed Trial - AP | N | N | 330007676 | MAP |
| 330007101 | 330010397 | 1.83 | 84.4 | Palliative (P) | 2016-06-29 | 2016-07-17 | Docetaxel + Gemcitabine (prior RT) | N | N | 330007692 | DOCETAXEL + GEMCITABINE |
| 330007102 | 330003888 | 1.63 | 79.6 | Curative (C) | 2014-12-29 | 2015-01-12 | MAP | 2 | N | 330007692 | MAP |
| 330007103 | 330003890 | null | 68 | null | null | 2014-08-08 | CETUXIMAB | N | N | 330007710 | CETUXIMAB |
| 330007104 | 330003891 | 1.78 | null | Neo-adjuvant (N) | 2014-02-12 | 2014-02-12 | CARBOPLATIN | 02 | N | 330007714 | CARBOPLATIN |